|

CD19-CAR-NK/T Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • Primary Mediastinal B-cell Lymphoma (PMBCL)1
  • Mantle Cell Lymphoma (MCL)1
  • Diffuse Large B-cell Lymphoma(DLBCL)1
  • Cancer1

Other1 trial

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.